Terms: = Breast cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2
235 results:
1. PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway.
Ma Y; Fang Z; Zhang H; Qi Y; Mao Y; Zheng J
Cell Death Dis; 2024 Apr; 15(3):199. PubMed ID: 38604999
[TBL] [Abstract] [Full Text] [Related]
2. The incremental healthcare cost associated with cancer in Belgium: A registry-based data analysis.
Gorasso V; Vandevijvere S; Van der Heyden J; Pelgrims I; Hilderink H; Nusselder W; Demoury C; Schmidt M; Vansteelandt S; De Smedt D; Devleesschauwer B
Cancer Med; 2024 Feb; 13(3):e6659. PubMed ID: 38268318
[TBL] [Abstract] [Full Text] [Related]
3. Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics.
Jiang W; Wu R; Yang T; Yu S; Xing W
Cancer Med; 2023 Dec; 12(24):21861-21872. PubMed ID: 38083903
[TBL] [Abstract] [Full Text] [Related]
4. Predictive value of triple negative breast cancer based on DCE-MRI multi-phase full-volume ROI clinical radiomics model.
Qi X; Wang W; Pan S; Liu G; Xia L; Duan S; He Y
Acta Radiol; 2024 Feb; 65(2):173-184. PubMed ID: 38017694
[TBL] [Abstract] [Full Text] [Related]
5. Kinetic Heterogeneity Improves the Specificity of Dynamic Enhanced MRI in Differentiating Benign and Malignant breast Tumours.
Yao Y; Mou F; Kong J; Liu X
Acad Radiol; 2024 Mar; 31(3):812-821. PubMed ID: 37980221
[TBL] [Abstract] [Full Text] [Related]
6. Impact of deep learning on radiologists and radiology residents in detecting breast cancer on CT: a cross-vendor test study.
Yasaka K; Sato C; Hirakawa H; Fujita N; Kurokawa M; Watanabe Y; Kubo T; Abe O
Clin Radiol; 2024 Jan; 79(1):e41-e47. PubMed ID: 37872026
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution.
Chen D; Wang Q; Dong M; Chen F; Huang A; Chen C; Lu Y; Zhao W; Wang L
BMC Cancer; 2023 Oct; 23(1):984. PubMed ID: 37845617
[TBL] [Abstract] [Full Text] [Related]
8. A Nomogram for Enhancing the Diagnostic Effectiveness of Solid breast BI-RADS 3-5 Masses to Determine Malignancy Based on Imaging Aspects of Conventional Ultrasonography and Contrast-Enhanced Ultrasound.
Yan M; Peng C; He D; Xu D; Yang C
Clin Breast Cancer; 2023 Oct; 23(7):693-703. PubMed ID: 37394416
[TBL] [Abstract] [Full Text] [Related]
9. Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer.
Flaum N; Bowes J; Smith MJ; Crosbie EJ; Edmondson R; Lophatananon A; Evans DG
Genet Med; 2023 Sep; 25(9):100898. PubMed ID: 37212253
[TBL] [Abstract] [Full Text] [Related]
10. The changes of subtype markers between first and second primary breast cancers.
Li C; Lyu Z; Wang Z; Hao C; Huang Y; Song F
Cancer Med; 2023 Jun; 12(12):13649-13660. PubMed ID: 37096879
[TBL] [Abstract] [Full Text] [Related]
11. Cobalamin (Vitamin B12) in Anticancer Photodynamic Therapy with Zn(II) Phthalocyanines.
Mantareva V; Iliev I; Sulikovska I; Durmuş M; Angelov I
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901830
[TBL] [Abstract] [Full Text] [Related]
12. Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study.
Coles B; Welch CA; Motiwale RS; Teece L; Oliver-Williams C; Weston C; de Belder MA; Lambert PC; Rutherford MJ; Paley L; Kadam UT; Lawson CA; Deanfield J; Peake MD; McDonagh T; Sweeting MJ; Adlam D;
Eur Heart J Acute Cardiovasc Care; 2023 May; 12(5):315-327. PubMed ID: 36888552
[TBL] [Abstract] [Full Text] [Related]
13. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies.
Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de Sa TH; Smith AD; Wijndaele K; Woodcock J; Brage S
Br J Sports Med; 2023 Aug; 57(15):979-989. PubMed ID: 36854652
[TBL] [Abstract] [Full Text] [Related]
14. Perceptions of breast cancer Risks Among Women Receiving Mammograph Screening.
Beidler LB; Kressin NR; Wormwood JB; Battaglia TA; Slanetz PJ; Gunn CM
JAMA Netw Open; 2023 Jan; 6(1):e2252209. PubMed ID: 36689223
[TBL] [Abstract] [Full Text] [Related]
15. [cbl inhibits proliferation and invasion of breast cancer cells by ubiquitylation-mediated degradation of NCK2].
Song X; Xiao B; Lu J; Zhang W; Li J; Zhu X; Sun Z; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1594-1603. PubMed ID: 36504051
[TBL] [Abstract] [Full Text] [Related]
16. Machine learning for identifying benign and malignant of thyroid tumors: A retrospective study of 2,423 patients.
Guo YY; Li ZJ; Du C; Gong J; Liao P; Zhang JX; Shao C
Front Public Health; 2022; 10():960740. PubMed ID: 36187616
[TBL] [Abstract] [Full Text] [Related]
17. Cost-Effectiveness Analysis of Pertuzumab Plus Trastuzumab and Docetaxel Compared With Trastuzumab and Docetaxel in the Adjuvant Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic breast cancer in Colombia.
Guevara-Cuellar CA; Parody-Rúa E; Rengifo-Mosquera MP; Del Mar Conde-Crespo M; Nuñez-Castro JM
Value Health Reg Issues; 2022 Nov; 32():109-118. PubMed ID: 36183606
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative Prediction of Axillary Lymph Node Metastasis in breast cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
Liu Y; Li X; Zhu L; Zhao Z; Wang T; Zhang X; Cai B; Li L; Ma M; Ma X; Ming J
Contrast Media Mol Imaging; 2022; 2022():6729473. PubMed ID: 36051932
[TBL] [Abstract] [Full Text] [Related]
19. Vitamin C-induced competitive binding of HIF-1α and p53 to ubiquitin E3 ligase cbl contributes to anti-breast cancer progression through p53 deacetylation.
Xiong Y; Xu S; Fu B; Tang W; Zaky MY; Tian R; Yao R; Zhang S; Zhao Q; Nian W; Lin X; Wu H
Food Chem Toxicol; 2022 Oct; 168():113321. PubMed ID: 35931247
[TBL] [Abstract] [Full Text] [Related]
20. The Abl/Abi signaling links WAVE regulatory complex to cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis.
Jiang P; Tang S; Hudgins H; Smalligan T; Zhou X; Kamat A; Dharmarpandi J; Naguib T; Liu X; Dai Z
Neoplasia; 2022 Oct; 32():100819. PubMed ID: 35839699
[TBL] [Abstract] [Full Text] [Related]
[Next]
